Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Ryan Irvine
Pyng Medical Corp.PYT.VHOLDAug 20, 2008
Has had a bit of a problem in producing steady quarter over quarter earnings. 1 to 2 years out the company has good solid potential. Good technology.
$0.41
Stock price when the opinion was issued
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
HOLD
Have a technology that delivers vital fluids to a patient in an emergency situation. Tremendous growth in earnings last year, up to about 4 1/2 cents per share. Has some lumpiness in its earnings traditionally. Good growth profile 1 to 2 years out.
Ryan IrvineOwned
biotechnologypharmaceutical
